What all successful laboratories have in common is the ability to combine efficient data management and cost optimization without compromising quality. For confident in-process and product release decisions, they need advanced and agile tools supporting streamlined workflows.
Industry-leading bioproduction companies are driving widespread adoption of recombinant Factor C (rFC). When compared side by side, the evidence is clear: rFC saves time, generates cost savings, reduces waste, and eliminates the impact on the horseshoe crab population.
View our infographic to find out how the bioMérieux ENDONEXT™ technology can benefit your day-to-day operations, reduce waste, and limit your impact on the environment.
BioMérieux’s ENDONEXT™ technology, based on recombinant Horseshoe Crab Factor C (rFC), has 100% endotoxin specificity, lot-to-lot consistency for greater laboratory efficiency, and competitive testing costs.
ENDONEXT™ does not require harvesting of horseshoe crab blood and offers long-lasting positive impacts on the planet by decreasing your laboratory environmental impact.
Learn more on how you can take a major step toward robust solutions that will support you in delivering on both your breakthrough products and sustainability goals.
